via University of Waterloo
Researchers at the University of Waterloo are developing a DNA-based vaccine that can be delivered through a nasal spray.
The vaccine will work by using bacteriophage, a process that will allow the vaccine to replicate within bacteria already in the body and is being designed to target tissues in the nasal cavity and lower respiratory tract.
“When complete, our DNA-based vaccine will be administered non-invasively as a nasal spray that delivers nanomedicine engineered to immunize and decrease COVID-19 infections,” explains Roderick Slavcev, a professor in the School of Pharmacy who specializes in designing vaccines, pharmaceuticals and gene-therapy treatments. “This research combines the expertise of many and leverages existing technology developed by my team, which we’re reconfiguring for a COVID-19 application.”
When completed, the researchers aim to have the DNA-based vaccine enter cells in targeted tissues and cause them to produce a virus-like particle (VLP) that will stimulate an immune response in people.
The VLP will look similar to the structure of SARS-CoV-2 (the virus which causes COVID-19), but is harmless. This similarity will activate the body’s natural immune response to protect against viral infections comparable to the VLP, including SARS-CoV-2. It will also bind to receptors that SARS-CoV-2 would bind to, limiting the possible sites for transmission. By causing these changes in the body, the vaccine will build immunity against COVID-19 and decrease the severity of infections in progress – serving as both a therapeutic and a vaccine.
Every detail of the vaccine, from ensuring the bacteriophage target specific cells in the respiratory tract to creating a minimal VLP to impersonate SARS-CoV-2, is specifically engineered by the researchers and requires testing.
To achieve the design of such a complex project, Slavcev is teaming up with Emmanuel Ho, another professor at the School of Pharmacy, and Marc Aucoin, professor of chemical engineering. Ho’s team is designing the nanomedication that will be delivered by the nasal spray, which is currently being tested. Aucoin’s lab is constructing and purifying the VLP and boosting immunity following the initial administration of the therapeutic vaccine.
“It is the collaborative effort of our talented teams that makes this multidisciplinary project so feasible and necessarily efficient as a potential universal vaccine solution against SARS-CoV infections,” says Slavcev. “To practice science with such urgency alongside such talented colleagues and their students is not only immensely educational, it is extremely rewarding.”
Slavcev’s team has completed design of the bacteriophage delivery system and is currently modifying this system to apply to COVID-19. Additional design of components and further testing will take place later this year. Components of the research are supported by a grant from the Natural Sciences and Engineering Research Council of Canada.
Note: This research has not yet been peer-reviewed and is being released as part of UWaterloo’s commitment to help inform Canada’s COVID-19 response.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
DNA-based COVID-19 vaccine
- Debunking COVID-19 myths
Some information you come across about COVID-19 may be out of date or false. Learn about COVID-19 myths so you can bust them when you see them.
- Leaked Video of Mark Zuckerberg Discussing Vaccines Omits Context
Snopes obtained a transcript of Zuckerberg's full answer, revealing context was missing from the original video.
- COVID-19 vaccines: Get the facts
Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...
- A one-shot vaccine for COVID, flu and future viruses? Researchers say it's coming
based on "viral vectors," uses DNA and RNA to give cells a blueprint, rather than a piece of the pathogen itself, to build immunity. MRNA vaccines, like the best-known vaccines against COVID-19 ...
- No, DNA fragments in COVID-19 vaccines aren't linked to 'major safety concerns'
A March 16 Instagram post shares a news report about a warning issued by the Florida surgeon general of purported risks associated with DNA fragments in COVID-19 mRNA vaccines. “There Are Major ...
Go deeper with Google Headlines on:
DNA-based COVID-19 vaccine
[google_news title=”” keyword=”DNA-based COVID-19 vaccine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
COVID-19 vaccine
- Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
A study has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes COVID-19,
- CDC's free COVID-19 vaccine program for uninsured to end in August instead of December
A spokesperson for the CDC said the program will expire at the end of August because its funding is running out. The program gives out the vaccines by partnering with CVS, Walgreens and eTrueNorth pharmacies.
Go deeper with Google Headlines on:
COVID-19 vaccine
[google_news title=”” keyword=”COVID-19 vaccine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]